Veidlapa Nr. M-3 (8)
Study Course Description
Pulmonary Circulation and Right Ventricular Function
Course Code
RKA_041
Branch of Science
Clinical medicine; Internal medicine
ECTS
2.00
Target Audience
Medicine
LQF
Level 8
Study Course Implementer
Course Supervisor
Andris Skride
Residency Speciality
Speciality
Cardiologist
Supervisor of Medical Speciality
Andris Skride
Contacts
-
About Study Course
Objective
To ensure the acquisition of theoretical knowledge and practical skills according to the more common diseases of the pulmonary circulation and right ventricular failure, examination methods and therapy for doctors specializing in cardiology.
Learning Outcomes
Knowledge
1.Knowledge test after the study course - test of theoretical knowledge (multiple-answer test questions, open, theoretical questions)
Skills
1.Pulmonary hypertension as a syndrome - investigation of patients. Interpretation of the most frequently used radiological (including echocardiography) and laboratory examinations in cardiology and pulmonology. Early recognition, treatment and prevention of thromboembolism. Right heart catheterization and pulmonary angiography. 6-minute walk test. Treatment options for pulmonary hypertension.
Competences
1.Independently applies medical problem-solving skills in disease prevention, diagnosis, and treatment. Skillfully performs manipulations, patient examination. Right heart catheterization and pulmonary angiography. Echocardiographic determination of right ventricle parameters.
Assessment
Examination
|
Title
|
% from total grade
|
Grade
|
|---|---|---|
|
1.
Examination |
-
|
-
|
Study Course Theme Plan
FULL-TIME
Part 1
Total ECTS (Creditpoints):
2.00
Number of Residency Seminars:
3
Length (weeks):
2
Final Examination:
Test
Bibliography
Other Information Sources
1.
Humbert M et al: 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 43(38):3618-731, 2022
2.
Simonneau G et al: Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 53(1):1801913, 2019
3.
Hoeper MM et al: COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J. 60(1):2102311, 2022
4.
Frost A et al: Diagnosis of pulmonary hypertension. Eur Respir J. 53(1):1801904, 2019
5.
Klinger JR et al: Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report. Chest. 155(3):565-86, 2019
6.
Morrell NW et al: Genetics and genomics of pulmonary arterial hypertension. Eur Respir J. 53(1):1801899, 2019
7.
Sharma M et al: Revisiting a distinct entity in pulmonary vascular disease: chronic thromboembolic pulmonary hypertension (CTEPH). Medicina (Kaunas). 57(4):355, 2021
8.
Konstantinides SV et al: 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 41(4):543-603, 2020
9.
Moore C et al: Challenges and changes to the management of pulmonary embolism in the emergency department. Clin Chest Med. 39(3):539-47, 2018
10.
Stevens SM et al: Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. ePub, 2021
11.
Sanz J., et al.: Anatomy, function, and dysfunction of the right ventricle. J Am Coll Cardiol 2019; 3 (12): pp. 1463-1482.
12.
Repessé X., et al.: Acute cor pulmonale in ARDS: rationale for protecting the right ventricle. Chest 2015; 147 (1): pp. 259-265
13.
Ghofrani H.A., et al.: Acute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary disease. Pulm Circ 2015; 5 (2): pp. 296-304